LLY

1,036.35

+1.36%↑

JNJ

199.78

+0.35%↑

ABBV

234.61

+0.57%↑

UNH

314.19

-2.11%↓

AZN

89.43

+0.25%↑

LLY

1,036.35

+1.36%↑

JNJ

199.78

+0.35%↑

ABBV

234.61

+0.57%↑

UNH

314.19

-2.11%↓

AZN

89.43

+0.25%↑

LLY

1,036.35

+1.36%↑

JNJ

199.78

+0.35%↑

ABBV

234.61

+0.57%↑

UNH

314.19

-2.11%↓

AZN

89.43

+0.25%↑

LLY

1,036.35

+1.36%↑

JNJ

199.78

+0.35%↑

ABBV

234.61

+0.57%↑

UNH

314.19

-2.11%↓

AZN

89.43

+0.25%↑

LLY

1,036.35

+1.36%↑

JNJ

199.78

+0.35%↑

ABBV

234.61

+0.57%↑

UNH

314.19

-2.11%↓

AZN

89.43

+0.25%↑

Search

West Pharmaceutical Services Inc

Open

BrancheGesundheitswesen

260.15 -0.8

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

255.78

Max

261.84

Schlüsselkennzahlen

By Trading Economics

Einkommen

8.2M

140M

Verkäufe

38M

804M

KGV

Branchendurchschnitt

40.81

105.69

EPS

1.96

Dividendenrendite

0.31

Gewinnspanne

17.406

Angestellte

10,600

EBITDA

17M

215M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+32.48% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.31%

2.37%

Nächste Dividendenausschüttung

19. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

51M

20B

Vorheriger Eröffnungskurs

260.95

Vorheriger Schlusskurs

260.15

Nachrichtenstimmung

By Acuity

50%

50%

185 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Nov. 2025, 18:59 UTC

Wichtige Markttreiber

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17. Nov. 2025, 23:40 UTC

Market Talk

Gold Consolidates Amid Mixed Signals -- Market Talk

17. Nov. 2025, 23:34 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17. Nov. 2025, 22:58 UTC

Market Talk

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17. Nov. 2025, 22:46 UTC

Market Talk

Risk Assets Set to Have a Strong 2026 -- Market Talk

17. Nov. 2025, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17. Nov. 2025, 22:02 UTC

Ergebnisse

Trip.com Group 3Q Rev $2.6B >TCOM

17. Nov. 2025, 22:02 UTC

Ergebnisse

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17. Nov. 2025, 22:02 UTC

Ergebnisse

Trip.com Group 3Q EPS $4.02 >TCOM

17. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Nov. 2025, 21:40 UTC

Ergebnisse

James Hardie Industries 2Q Adj EPS 26c >JHX

17. Nov. 2025, 21:40 UTC

Ergebnisse

James Hardie Industries 2Q Loss/Shr 10c >JHX

17. Nov. 2025, 21:39 UTC

Ergebnisse

James Hardie Industries 2Q Sales $1.29B >JHX

17. Nov. 2025, 21:38 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17. Nov. 2025, 21:38 UTC

Ergebnisse

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17. Nov. 2025, 21:10 UTC

Ergebnisse

XP Inc. 3Q EPS BRL2.47 >XP

17. Nov. 2025, 21:10 UTC

Ergebnisse

XP Inc. 3Q Rev BRL4.67B >XP

17. Nov. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17. Nov. 2025, 20:12 UTC

Market Talk

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17. Nov. 2025, 20:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Nov. 2025, 20:09 UTC

Market Talk

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17. Nov. 2025, 19:29 UTC

Market Talk

Gold Slide Continues to Start Week -- Market Talk

17. Nov. 2025, 19:16 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17. Nov. 2025, 18:20 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17. Nov. 2025, 16:45 UTC

Akquisitionen, Fusionen, Übernahmen

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17. Nov. 2025, 16:16 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17. Nov. 2025, 16:15 UTC

Ergebnisse

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17. Nov. 2025, 15:40 UTC

Akquisitionen, Fusionen, Übernahmen

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17. Nov. 2025, 15:22 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17. Nov. 2025, 15:19 UTC

Market Talk

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Peer-Vergleich

Kursveränderung

West Pharmaceutical Services Inc Prognose

Kursziel

By TipRanks

32.48% Vorteil

12-Monats-Prognose

Durchschnitt 347.63 USD  32.48%

Hoch 375 USD

Tief 311 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für West Pharmaceutical Services Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

9

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

213.26 / 219.27Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

185 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat